Security key
G9442G138
Universe Pharmaceuticals INC - Class A ordinary shares (UPC)
CUSIP: G9442G138
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Class A ordinary shares
- Total 13F shares
- 44,531
- Total 13F value
- $191,483
- Share change
- +44,531
- SEC-reported price per share
- $4.30
- Number of holders
- 1
- Value change
- +$191,483
- Number of buys
- 1
- Shares outstanding
- 5,009,225
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
1
Top holders
1
UPC full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q2 2026
Universe Pharmaceuticals INC SEC filings
Universe Pharmaceuticals INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP G9442G138
Recent filing periods:
Ownership snapshot
Top reported holders of UPC - Universe Pharmaceuticals INC - Class A ordinary shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Piao Ye
Disclosed value leader
Piao Ye
Comparable rows
10/15
Latest evidence
30 Jul 2026
13D/G
3/4/5
13F
Lead comparable stake: 18%
5 rows are not safely comparable across share classes.
13D/G row: Piao Ye
Showing 1-6 of 15 holder rows.
Quick read
Piao Ye leads the comparable SEC ownership view at 18%.
10 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Piao Ye's linked filing trail.
Comparable ownership
Top 5
Piao Ye
18%
Chunhua Zheng
10%
Chengming Tang
10%
Shan Xie
10%
Lu (nmn) Yang
10%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Piao Ye |
13D/G
Origin Force Intelligence Limited
|
18%
Reported 13D/G
· 27 Jul 2026
|
$5,555,560
916,759 shares
|
$0 | 27 Jul 2026 |
| Chunhua Zheng |
13D/G
Orbis BioCapital Limited
|
10%
Reported 13D/G
· 27 Jul 2026
|
$3,029,552
499,926 shares
|
$0 | 27 Jul 2026 |
| Chengming Tang |
13D/G
Whitmore Limited
|
10%
Reported 13D/G
· 27 Jul 2026
|
$3,026,509
499,424 shares
|
$0 | 27 Jul 2026 |
| Shan Xie |
13D/G
Horizon Ridge Limited
|
10%
Reported 13D/G
· 27 Jul 2026
|
$3,026,509
499,424 shares
|
$0 | 27 Jul 2026 |
| Lu (nmn) Yang |
13D/G
Clever Way Global Limited
|
10%
Reported 13D/G
· 27 Jul 2026
|
$3,023,467
498,922 shares
|
$0 | 27 Jul 2026 |
| Shanshan Lu |
13D/G
Meridian Prosperous Limited
|
10%
Reported 13D/G
· 30 Jul 2026
|
$3,023,467
498,922 shares
|
$0 | 30 Jul 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
44,531
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
4
Q3 2026 holders
1
Holder diff
-3
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend